OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)

OPTUS Pharmaceutical Revenue

OPTUS Pharmaceutical had revenue of 24.07B KRW in the quarter ending September 30, 2025, with 24.67% growth. This brings the company's revenue in the last twelve months to 87.58B, up 11.13% year-over-year. In the year 2024, OPTUS Pharmaceutical had annual revenue of 81.90B with 13.09% growth.

• Revenue (ttm): 87.58B
• Revenue Growth: +11.13%
• P/S Ratio: 1.41
• Revenue / Employee: 550.80M
• Employees: 159
• Market Cap: 123.35B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	81.90B	9.48B	13.09%
Dec 31, 2023	72.43B	13.77B	23.47%
Dec 31, 2022	58.66B	1.34B	2.34%
Dec 31, 2021	57.32B	-3.51B	-5.77%
Dec 31, 2020	60.83B	385.58M	0.64%